Background: The purpose of this study was to determine the profiles patients with type 2 diabetes (T2DM) and an SLC22A1 gene mutation in order evaluate effect metformin pharmacogenetics.
 Methods: To assess pharmacogenetics, a T2DM receiving investigated. Blood samples were taken from 50 diabetics Minangkabau ethnicity who met inclusion criteria, SNP genotyping blood glucose levels determi...